Penumbra, Inc. announced the initiation of its FORWARD study, which will collect safety and efficacy data on mechanical ...
Penumbra, which is set to become part of Boston Scientific this year, is running the trial to inform the treatment of a type of medium-vessel blockage.
Diversity, equity, and inclusion (DEI) champions: Lessons learned and implications for future programming to support cancer clinical trials. This is an ASCO Meeting Abstract from the 2023 ASCO Annual ...
The analyses were part of the BliTz study (Begleitende Evaluierung innovativer Testverfahren zur Darmkrebsfrüherkennung), an ongoing screening study conducted in cooperation with 20 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results